申请人:IGNYTA, INC.
公开号:US20170320853A1
公开(公告)日:2017-11-09
The present invention provides compounds of Formula I
or pharmaceutically acceptable salt forms thereof, wherein R
a
, R
b
, R
c
, R
d
, D, W, R
1a
, R
1b
, R
1c
,Y, R
3
, X, E and G are as defined herein, methods of treatment and uses thereof.